Fund Evaluator:
FM Compounders Equity ETF (FMCE)
Follow This Fund
Equity
Global Asset Class
U.S. Equity
Fund Group
Large Blend
Category
$0.000
NAV (as of )
$0.00
Minimum Initial
0.71% F
Expense Ratio
$68 Mil
Assets
Open
Status
na
12b-1 Fee
0.67%
TTM Yield
0.00%
Max Load
46%
Portfolio Turnover
Best Performing in Large Blend Over the Last Year
| 49.8% | PRIMECAP Odyssey Growth (POGRX) |
| 48.6% | Vanguard PRIMECAP Core Inv (VPCCX) |
| 45.8% | Vanguard PRIMECAP Adm (VPMAX) |
| 45.7% | Vanguard PRIMECAP Inv (VPMCX) |
| 42.3% | Midas Special Opportunities (MISEX) |
Data as of 7/31/2026
-2.0% D
1-Mo Return
3.3% F
3-Mo Return
7.9% D
YTD Return
11.3% F
1-Yr Return
na
3-Yr Return
na
5-Yr Return
na
Category Risk Index
na
Total Risk Index
Fund Details
Fund Family
First Manhattan Co.
Inception Date
11/8/2024
Share Class Type
Equity Investment Style
Large-Cap
Blend
Bond Investment Style
na
Socially Responsible Fund
No
Index Fund
No
Benchmark Index
S&P 500 Equal Weighted TR USD: 100%
Additional Fund Details
FM Compounders Equity ETF Overview
FMCE Trailing NAV Total Returns Data as of 7/31/26
| Last Month |
Last Quarter |
Ann'l. 1Yr |
Ann'l. 3Yr |
Ann'l. 5Yr |
Ann'l. 10Yr |
|
| FMCE Return (NAV) | -2.0% | 3.3% | 11.3% | na | na | na |
| FMCE Grade | D | F | F | na | na | na |
| +/- Category | -2.4% | -0.8% | -6.1% | na | na | na |
| Large Blend Avg | 0.4% | 4.1% | 17.5% | 17.3% | 11.1% | 13.7% |
| FMCE Tax Cost Ratio | na | na | 0.8% | na | na | na |
FMCE Annual NAV Total ReturnsData as of 7/31/26
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
| FMCE Return (NAV) | 7.9% | 10.9% | na | na | na | na | na | na | na | na | na |
| FMCE Grade | D | F | na | na | na | na | na | na | na | na | na |
| +/- Category | -1.4% | -5.0% | na | na | na | na | na | na | na | na | na |
| Large Blend Avg | 9.3% | 15.8% | 22.1% | 23.7% | -17.3% | 26.5% | 17.5% | 29.8% | -5.9% | 21.3% | 10.2% |
| Risk Measures | |
| Standard Deviation: | na |
| Total Risk Index: | na |
| Category Risk Index: | na |
| Category Risk Grade: | |
| Beta: | na |
| R-Squared: | na |
| Leveraged Fund: | No |
| Inverse Fund: | No |
| Portfolio Characteristics | |
| Equity Investment Style: | Large-Cap Blend |
| Bond Investment Style: | na |
| Yield: | 0.7% |
| Dividend Distribution: | Semi-Annually |
| Cap Gains Distribution: | Annually |
| Total Assets: | $68 Mil |
| Fund Total Assets: | $ 68 Mil |
| Share Class Type: | |
| Portfolio Turnover: | 46% |
Management Team
| Number of Managers: 1 | |||
| Longest Tenure: 1.7 years | |||
| Average Tenure: 1.7 years | |||
| Managers (Year): Puri Himayani (2024) | |||
Portfolio Composition (as of 2/28/26)
| # of Holdings: | 31 |
| % in Top 10 Holdings: | 47.8% |
| Fund is Non-Diversified: | Yes |
| % in Foreign Issues: | 3.8% |
Portfolio Allocation |
|
| Domestic Stock: | 86.4% |
| Foreign Stock: | 3.8% |
| Preferred Stock: | 0.0% |
| Domestic Bond: | 0.0% |
| Foreign Bond: | 0.0% |
| Convertible Bond: | 0.0% |
| Other: | 0.0% |
| Cash: | 9.9% |
Purchase Information
| Fund Family: | First Manhattan Co. |
| Phone Number: | 888-530-2448 |
| Website: |
| Status: | Open |
| Inception Date: | November 8, 2024 |
| Min. Initial Purchase: | $ 0 |
| Min. Initial IRA Purchase: | $ 0 |
| True No-Load: | Yes |
| Front Load Maximum: | 0.00% |
| Deferred Charge Maximum: | 0.00% |
| Redemption Charge Maximum: | 0.00% |
| 12b-1 Fee: | na |
Expenses and Fees | |
| Expense Ratio (%): | 0.71% ( Rating : Above Avg ) |
| Category Average Expense Ratio (%): | 0.81% |
| Share Class: | FM Compounders Equity ETF |
| Min. Subsequent Purchase: | $ 0 |
| Min. Subsequent IRA Purchase: | $ 0 |
Copyright 2026 American Association of Individual Investors and Morningstar, Inc. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.